Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature.

brain biopsy cyclophosphamide marburg-variant rituximab tumefactive multiple sclerosis

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2020
Historique:
received: 02 03 2020
accepted: 14 05 2020
entrez: 28 7 2020
pubmed: 28 7 2020
medline: 28 7 2020
Statut: epublish

Résumé

Atypical forms of demyelinating diseases with tumor-like lesions and aggressive course represent a diagnostic and therapeutic challenge for neurologists. Herein, we describe a 50-year-old woman presenting with subacute onset of left hemiparesis, memory difficulties and headache. Brain MRI revealed a tumefactive right frontal-parietal lesion with perilesional edema, mass effect and homogenous post-contrast enhancement, along with other small atypical lesions in the white-matter. Brain biopsy of cerebral lesion ruled out lymphoma or any other neoplastic process and patient placed on corticosteroids with complete clinical/radiological remission. Two years after disease initiation, there was disease exacerbation with reappearance of the tumor-like mass. The patient initially responded to high doses of corticosteroids but soon became resistant. Plasma-exchange sessions were not able to limit disease burden. Resistance to therapeutic efforts led to a second biopsy that showed perivascular demyelination, predominantly consisting of macrophages, with a small number of T and B lymphocytes, and the presence of reactive astrocytes, typical of Creutzfeldt-Peters cells. The patient received high doses of cyclophosphamide with substantial clinical/radiological response but relapsed after 7-intensive cycles. She received 4-weekly doses of rituximab with disease exacerbation and brainstem involvement. She eventually died with complicated pneumonia. We present a very rare case of recurrent tumefactive demyelinating lesions, with atypical tumor-like characteristics, with initial response to corticosteroids and cyclophosphamide, but subsequent development of drug-resistance and unexpected exacerbation upon rituximab administration. Our clinical case raises therapeutic dilemmas and points to the need for immediate and appropriate immunosuppression in difficult to treat tumefactive CNS lesions with Marburg-like features.

Identifiants

pubmed: 32714265
doi: 10.3389/fneur.2020.00536
pmc: PMC7344179
doi:

Types de publication

Journal Article

Langues

eng

Pagination

536

Informations de copyright

Copyright © 2020 Vakrakou, Tzanetakos, Argyrakos, Koutsis, Evangelopoulos, Andreadou, Anagnostouli, Breza, Tzartos, Gialafos, Dimitrakopoulos, Velonakis, Toulas, Stefanis and Kilidireas.

Références

Mult Scler. 2014 Apr;20(5):631-3
pubmed: 24347182
Mult Scler J Exp Transl Clin. 2019 Jun 18;5(2):2055217319855755
pubmed: 31245023
Rev Neurol (Paris). 2018 Jun;174(6):408-418
pubmed: 29673573
J Neurol. 2012 May;259(5):801-16
pubmed: 21932127
Brain Tumor Pathol. 2011 Jul;28(3):229-38
pubmed: 21442242
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1338-9
pubmed: 23804236
Acta Neurol Scand. 1992 Dec;86(6):579-85
pubmed: 1481644
J Neuroinflammation. 2011 Oct 26;8:146
pubmed: 22027448
Curr Opin Neurol. 2019 Jun;32(3):467-474
pubmed: 30844860
Clin Neurol Neurosurg. 2012 Dec;114(10):1326-8
pubmed: 22475882
J Neurol Sci. 2017 Oct 15;381:32-38
pubmed: 28991707
J Clin Neurosci. 2011 Jul;18(7):997-8
pubmed: 21565508
J Neuroimaging. 2004 Jan;14(1):58-62
pubmed: 14748210
Intern Med. 2018 Sep 15;57(18):2647-2655
pubmed: 29709955
J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):918-21
pubmed: 2266377
Neurosurg Rev. 2009 Apr;32(2):171-9; discussion 179
pubmed: 19172322
Semin Immunopathol. 2009 Nov;31(4):439-53
pubmed: 19779719
Ann Neurol. 1999 Dec;46(6):878-86
pubmed: 10589540
Mult Scler Relat Disord. 2015 Nov;4(6):555-66
pubmed: 26590662
Neurol Sci. 2010 Dec;31(6):807-11
pubmed: 20461429
Neurol Neuroimmunol Neuroinflamm. 2014 Oct 09;1(3):e34
pubmed: 25340086
AJNR Am J Neuroradiol. 2002 Sep;23(8):1378-86
pubmed: 12223381
Mult Scler. 2016 Oct;22(12):1541-1549
pubmed: 26869529
AJNR Am J Neuroradiol. 2007 Feb;28(2):272-7
pubmed: 17296993
Ann Neurol. 2014 Mar;75(3):411-28
pubmed: 24700511
Mult Scler. 2016 Jul;22(8):986-92
pubmed: 27037180
Neurol Neuroimmunol Neuroinflamm. 2018 Dec 13;6(1):e527
pubmed: 30588483
Mult Scler Relat Disord. 2020 Jul;42:102060
pubmed: 32217464
Mult Scler Relat Disord. 2017 May;14:72-79
pubmed: 28619436
Ann Neurol. 1996 Jul;40(1):18-24
pubmed: 8687186
J Neurol. 2008 Aug;255(8):1272-3
pubmed: 18677644
Neurol Neuroimmunol Neuroinflamm. 2015 Feb 05;2(1):e61
pubmed: 25738163
J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):1047-53
pubmed: 23334629
J Neurol Sci. 2020 Mar 15;410:116673
pubmed: 31954354
Lancet Neurol. 2016 Aug;15(9):967-981
pubmed: 27478954
Mult Scler Relat Disord. 2017 Oct;17:9-11
pubmed: 29055482
Brain. 2008 Jul;131(Pt 7):1759-75
pubmed: 18535080
Nat Immunol. 2002 Oct;3(10):944-50
pubmed: 12244307
Clin Nucl Med. 2018 Nov;43(11):e385-e391
pubmed: 30153143
Mult Scler. 2015 Apr;21(4):485-7
pubmed: 25824955
Mult Scler Relat Disord. 2019 Jun;31:62-64
pubmed: 30933712
Neurology. 1993 Jun;43(6):1100-4
pubmed: 8170550
Curr Neurol Neurosci Rep. 2016 Mar;16(3):26
pubmed: 26847090
Ann Clin Transl Neurol. 2015 Mar;2(3):295-301
pubmed: 25815356
Mult Scler Relat Disord. 2018 Oct;25:95-98
pubmed: 30056362
Mult Scler. 2018 Jul;24(8):1133-1137
pubmed: 29708466
Pract Neurol. 2015 Dec;15(6):451-5
pubmed: 26088612
Mult Scler Relat Disord. 2019 Jun;31:51-53
pubmed: 30925320

Auteurs

Aigli G Vakrakou (AG)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Dimitrios Tzanetakos (D)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Theodore Argyrakos (T)

Department of Pathology, Evaggelismos Hospital, Athens, Greece.

Georgios Koutsis (G)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Maria-Eleptheria Evangelopoulos (ME)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Elisabeth Andreadou (E)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Maria Anagnostouli (M)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Marianthi Breza (M)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

John S Tzartos (JS)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Elias Gialafos (E)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Antonios N Dimitrakopoulos (AN)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Georgios Velonakis (G)

Research Unit of Radiology, 2nd Department of Radiology, National and Kapodistrian University of Athens, Athens, Greece.

Panagiotis Toulas (P)

Research Unit of Radiology, 2nd Department of Radiology, National and Kapodistrian University of Athens, Athens, Greece.

Leonidas Stefanis (L)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Constantinos Kilidireas (C)

Demyelinating Diseases Unit, 1st Department of Neurology, School of Medicine, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Classifications MeSH